Annovis Bio holds special stockholder meeting
ANVS•Annovis Bio shareholders approved increasing authorized common stock from 70 million to 140 million shares at a November 3 special meeting. The charter amendment was filed November 4, and shareholders also approved an increase in shares authorized under the 2019 Equity Incentive Plan.
1. Shareholder approvals
Shareholders approved increasing Annovis Bio’s authorized common stock from 70 million to 140 million shares at the November 3, 2026, special meeting. The company filed the charter amendment on November 4. Shareholders also ratified an amendment increasing shares authorized under the 2019 Equity Incentive Plan; the adjournment proposal was not voted on because sufficient votes had been secured for both amendments.
